Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Sep;80(9):844–848. doi: 10.1136/bjo.80.9.844

The possible impact of uveitis in blindness: a literature survey.

M S Suttorp-Schulten 1, A Rothova 1
PMCID: PMC505625  PMID: 8962842

Full text

PDF
844

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abiose A., Murdoch I., Babalola O., Cousens S., Liman I., Onyema J., Evans J., Gregory W., Jones B. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol. 1994 Jan;78(1):8–13. doi: 10.1136/bjo.78.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aclimandos W. A., Galloway N. R. Blindness in the city of Nottingham (1980-1985). Eye (Lond) 1988;2(Pt 4):431–434. doi: 10.1038/eye.1988.78. [DOI] [PubMed] [Google Scholar]
  3. Baarsma G. S. The epidemiology and genetics of endogenous uveitis: a review. Curr Eye Res. 1992;11 (Suppl):1–9. doi: 10.3109/02713689208999505. [DOI] [PubMed] [Google Scholar]
  4. Bloch-Michel E., Nussenblatt R. B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987 Feb 15;103(2):234–235. doi: 10.1016/s0002-9394(14)74235-7. [DOI] [PubMed] [Google Scholar]
  5. Bressler N. M., Bressler S. B., West S. K., Fine S. L., Taylor H. R. The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol. 1989 Jun;107(6):847–852. doi: 10.1001/archopht.1989.01070010869032. [DOI] [PubMed] [Google Scholar]
  6. Chiang Y. P., Bassi L. J., Javitt J. C. Federal budgetary costs of blindness. Milbank Q. 1992;70(2):319–340. [PubMed] [Google Scholar]
  7. DARRELL R. W., WAGENER H. P., KURLAND L. T. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol. 1962 Oct;68:502–514. doi: 10.1001/archopht.1962.00960030506014. [DOI] [PubMed] [Google Scholar]
  8. Drews C. D., Yeargin-Allsopp M., Murphy C. C., Decoufle P. Legal blindness among 10-year-old children in Metropolitan Atlanta: prevalence, 1985 to 1987. Am J Public Health. 1992 Oct;82(10):1377–1379. doi: 10.2105/ajph.82.10.1377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foster A., Johnson G. J. Magnitude and causes of blindness in the developing world. Int Ophthalmol. 1990 May;14(3):135–140. doi: 10.1007/BF00158310. [DOI] [PubMed] [Google Scholar]
  10. Foster A. Who will operate on Africa's 3 million curably blind people? Lancet. 1991 May 25;337(8752):1267–1269. doi: 10.1016/0140-6736(91)92929-v. [DOI] [PubMed] [Google Scholar]
  11. Goggin M., O'Keefe M. Childhood blindness in the Republic of Ireland: a national survey. Br J Ophthalmol. 1991 Jul;75(7):425–429. doi: 10.1136/bjo.75.7.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hyman L. Epidemiology of eye disease in the elderly. Eye (Lond) 1987;1(Pt 2):330–341. doi: 10.1038/eye.1987.53. [DOI] [PubMed] [Google Scholar]
  13. Javitt J. C. Preventing blindness in Americans: the need for eye health education. Surv Ophthalmol. 1995 Jul-Aug;40(1):41–44. doi: 10.1016/s0039-6257(95)80045-x. [DOI] [PubMed] [Google Scholar]
  14. Javitt J. C. Universal coverage and preventable blindness. Arch Ophthalmol. 1994 Apr;112(4):453–453. doi: 10.1001/archopht.1994.01090160029011. [DOI] [PubMed] [Google Scholar]
  15. Johnson G. J., Minassian D. C. Prevalence of blindness and eye disease: discussion paper. J R Soc Med. 1989 Jun;82(6):351–354. doi: 10.1177/014107688908200613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Klein R., Klein B. E., Linton K. L. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992 Jun;99(6):933–943. doi: 10.1016/s0161-6420(92)31871-8. [DOI] [PubMed] [Google Scholar]
  17. Knox D. L. Epidemiology of uveitis. Trans Ophthalmol Soc U K. 1981 Sep;101(3):294–296. [PubMed] [Google Scholar]
  18. Krumpaszky H. G., Klauss V. Erblindungsursachen in Bayern. Auswertung einer repräsentativen Stichprobe der Blindengeldakten aus Oberbayern. Klin Monbl Augenheilkd. 1992 Feb;200(2):142–146. doi: 10.1055/s-2008-1045729. [DOI] [PubMed] [Google Scholar]
  19. Lee C. M., Olk R. J. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology. 1991 Oct;98(10):1594–1602. doi: 10.1016/s0161-6420(91)32082-7. [DOI] [PubMed] [Google Scholar]
  20. Leibowitz H. M., Krueger D. E., Maunder L. R., Milton R. C., Kini M. M., Kahn H. A., Nickerson R. J., Pool J., Colton T. L., Ganley J. P. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980 May-Jun;24(Suppl):335–610. [PubMed] [Google Scholar]
  21. Linssen A., Meenken C. Outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis. Am J Ophthalmol. 1995 Sep;120(3):351–361. doi: 10.1016/s0002-9394(14)72165-8. [DOI] [PubMed] [Google Scholar]
  22. Makabe R., Hellwig A. Wandel der Erblindungsursachen in jüngster Zeit. Versicherungsmedizin. 1988 Sep 1;40(5):136–139. [PubMed] [Google Scholar]
  23. Miettinen R. Incidence of uveitis in Northern Finland. Acta Ophthalmol (Copenh) 1977 Apr;55(2):252–260. doi: 10.1111/j.1755-3768.1977.tb01306.x. [DOI] [PubMed] [Google Scholar]
  24. Moss S. E., Klein R., Klein B. E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994 Jun;101(6):1061–1070. doi: 10.1016/s0161-6420(94)31217-6. [DOI] [PubMed] [Google Scholar]
  25. Nussenblatt R. B. The natural history of uveitis. Int Ophthalmol. 1990 Oct;14(5-6):303–308. doi: 10.1007/BF00163549. [DOI] [PubMed] [Google Scholar]
  26. Olurin O. Etiology of blindness in Nigerian children. Am J Ophthalmol. 1970 Oct;70(4):533–540. doi: 10.1016/0002-9394(70)90886-x. [DOI] [PubMed] [Google Scholar]
  27. Perkins E. S., Folk J. Uveitis in London and Iowa. Ophthalmologica. 1984;189(1-2):36–40. doi: 10.1159/000309382. [DOI] [PubMed] [Google Scholar]
  28. Potter A. R. Causes of blindness and visual handicap in the Central African Republic. Br J Ophthalmol. 1991 Jun;75(6):326–328. doi: 10.1136/bjo.75.6.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Potter A. R. Preventing blindness worldwide. BMJ. 1994 Sep 17;309(6956):682–683. doi: 10.1136/bmj.309.6956.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Quana'a P., Alemu B., Alemayehu W. Causes of blindness observed in the Eye Department of an Addis Ababa Hospital. Ethiop Med J. 1986 Jan;24(1):19–23. [PubMed] [Google Scholar]
  31. Roarty J. D., Fisher E. J., Nussbaum J. J. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1993 Nov;100(11):1685–1688. doi: 10.1016/s0161-6420(93)31417-x. [DOI] [PubMed] [Google Scholar]
  32. Robinson R., Deutsch J., Jones H. S., Youngson-Reilly S., Hamlin D. M., Dhurjon L., Fielder A. R. Unrecognised and unregistered visual impairment. Br J Ophthalmol. 1994 Oct;78(10):736–740. doi: 10.1136/bjo.78.10.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ronday M. J., Stilma J. S., Barbe R. F., Kijlstra A., Rothova A. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol. 1994 Sep;78(9):690–693. doi: 10.1136/bjo.78.9.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rosenberg T., Flage T., Hansen E., Riise R., Rudanko S. L., Viggosson G., Tornqvist K. Incidence of registered visual impairment in the Nordic child population. Br J Ophthalmol. 1996 Jan;80(1):49–53. doi: 10.1136/bjo.80.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rothova A., Alberts C., Glasius E., Kijlstra A., Buitenhuis H. J., Breebaart A. C. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989 Aug;72(3-4):287–296. doi: 10.1007/BF00153496. [DOI] [PubMed] [Google Scholar]
  36. Rothova A., Buitenhuis H. J., Meenken C., Brinkman C. J., Linssen A., Alberts C., Luyendijk L., Kijlstra A. Uveitis and systemic disease. Br J Ophthalmol. 1992 Mar;76(3):137–141. doi: 10.1136/bjo.76.3.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rothova A., Meenken C., Buitenhuis H. J., Brinkman C. J., Baarsma G. S., Boen-Tan T. N., de Jong P. T., Klaassen-Broekema N., Schweitzer C. M., Timmerman Z. Therapy for ocular toxoplasmosis. Am J Ophthalmol. 1993 Apr 15;115(4):517–523. doi: 10.1016/s0002-9394(14)74456-3. [DOI] [PubMed] [Google Scholar]
  38. Rothova A. Ocular involvement in toxoplasmosis. Br J Ophthalmol. 1993 Jun;77(6):371–377. doi: 10.1136/bjo.77.6.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rothova A., Suttorp-van Schulten M. S., Frits Treffers W., Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996 Apr;80(4):332–336. doi: 10.1136/bjo.80.4.332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rothova A., Van der Lelij A., Stilma J. S., Klaassen-Broekema N., Wilson W. R., Barbe R. F. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Am J Ophthalmol. 1990 Jul 15;110(1):6–16. doi: 10.1016/s0002-9394(14)76930-2. [DOI] [PubMed] [Google Scholar]
  41. Schmidt U., Murken J., Klauss V. Wandel der Blindheitsursachen im Kindesalter. Klin Monbl Augenheilkd. 1988 Nov;193(5):457–464. doi: 10.1055/s-2008-1050282. [DOI] [PubMed] [Google Scholar]
  42. Smit R. L., Baarsma G. S., de Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993 Apr;17(2):71–76. doi: 10.1007/BF00942778. [DOI] [PubMed] [Google Scholar]
  43. Stilma J. S., Bridger S. Causes and prevalence of blindness in the Northern Province of Sierra Leone. Doc Ophthalmol. 1983 Dec 15;56(1-2):115–122. doi: 10.1007/BF00154717. [DOI] [PubMed] [Google Scholar]
  44. Thompson J. R., Du L., Rosenthal A. R. Recent trends in the registration of blindness and partial sight in Leicestershire. Br J Ophthalmol. 1989 Feb;73(2):95–99. doi: 10.1136/bjo.73.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Thylefors B. A simplified methodology for the assessment of blindness and its main causes. World Health Stat Q. 1987;40(2):129–141. [PubMed] [Google Scholar]
  46. Thylefors B., Négrel A. D., Pararajasegaram R., Dadzie K. Y. Global data on blindness. Bull World Health Organ. 1995;73(1):115–121. [PMC free article] [PubMed] [Google Scholar]
  47. Tielsch J. M., Javitt J. C., Coleman A., Katz J., Sommer A. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med. 1995 May 4;332(18):1205–1209. doi: 10.1056/NEJM199505043321806. [DOI] [PubMed] [Google Scholar]
  48. Tielsch J. M., Sommer A., Witt K., Katz J., Royall R. M. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol. 1990 Feb;108(2):286–290. doi: 10.1001/archopht.1990.01070040138048. [DOI] [PubMed] [Google Scholar]
  49. Vingerling J. R., Dielemans I., Hofman A., Grobbee D. E., Hijmering M., Kramer C. F., de Jong P. T. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995 Feb;102(2):205–210. doi: 10.1016/s0161-6420(95)31034-2. [DOI] [PubMed] [Google Scholar]
  50. Waddell K. M., Saunderson P. R. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Br J Ophthalmol. 1995 Mar;79(3):250–256. doi: 10.1136/bjo.79.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Weiss H., Annesley W. H., Jr, Shields J. A., Tomer T., Christopherson K. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979 Feb;87(2):133–142. doi: 10.1016/0002-9394(79)90131-4. [DOI] [PubMed] [Google Scholar]
  52. Whitworth J. A., Gilbert C. E., Mabey D. M., Morgan D., Foster A. Visual loss in an onchocerciasis endemic community in Sierra Leone. Br J Ophthalmol. 1993 Jan;77(1):30–32. doi: 10.1136/bjo.77.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wormald R. P., Wright L. A., Courtney P., Beaumont B., Haines A. P. Visual problems in the elderly population and implications for services. BMJ. 1992 May 9;304(6836):1226–1229. doi: 10.1136/bmj.304.6836.1226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wormald R., Evans J. Registration of blind and partially sighted people. Br J Ophthalmol. 1994 Oct;78(10):733–734. doi: 10.1136/bjo.78.10.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol. 1982 Jan 29;52(3-4):279–285. doi: 10.1007/BF01675857. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES